LIST OF APPROVED DRUG FROM 01-01-2014 to 11.07.2014
1
Regorafenib film coated
tablet 40 mg
2
Azacitidine for injection
100 mg/vial
Tulobuterol Transdermal
Patch 0.5 mg/ 1.0 mg /
2.0 mg.
Pegaspargase Injection 3,750
Indicated as a component of multi agent
chemotherapeutic regimen for the
IU/5 mL
treatment
of patients with acute
lymphoblastic leukemia who are
hypersensitive to asparaginase
Tolterodine Tartrate
For the treatment of overactive bladder with
Extended release tablets
symptoms of urge urinary incontinence,
2mg/4mg
urinary incontinence, urgency and frequency
(Additional Dosage Form)
3
4
5
6
7
8
Bortezomib for injection
3.5mg (Sub-cutaneous
route of administration as
an alternate to
intravenous route)
(Additional route of
administration)
Paclitaxel Injection
Concentrate for
Nanodispersion 100mg
and 300mg
(Additional Dosage Form)
Heparin Sodium Topical
Solution 1000 IU/ml
(Additional Dosage Form)
For the “treatment of patients with
11.07.2014
metastatic colorectal cancer (CRC) who have
been previously treated with
fluoropyrimidine, oxaliplatin and irinotecanbase chemotherapy, ananti-VEGF therapy,
and, if KRAS wild type, an anti-EGFR
therapy”.
For the treatment of adult patients with all
15.05.14
subtypes of Myelodysplastic Syndrome
For treatment of patients with Asthma and
15.05.14
COPD without co-morbidity
Same as already approved
01.05.14
31.01.14
28.01.14
For the treatment of Breast cancer after
22.01.2014
failure of combination therapy metastatic
disease or relapse within six months of
adjuvant chemotherapy. Prior therapy
should have included an anthracycline unless
clinically contraindicated
16.01.2014
For the management of post infusion
superficial thrombophlebitis.